Aytu BioPharma Inc

Research Aytu BioPharma Inc (AYTU) on Bullrun: market cap USD 23.51M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerAYTU
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 23.51M
• Financial periodFY2025
• RevenueUSD 66.38M
• Revenue growth1.8%
• Net income-USD 13.56M
• Free cash flow-USD 2.17M
• Gross margin69.0%

Valuation Snapshot

latest market cap is USD 23.51M.

About Aytu BioPharma Inc

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old;

Frequently asked questions

What is Aytu BioPharma Inc's market cap?

Aytu BioPharma Inc's market capitalization is USD 23.51M.

What does Aytu BioPharma Inc do?

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally.